Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Warren Buffett, a few of the successful dividend investors in history, owes much of his financial success to a straightforward yet powerful strategy: dividend reinvestment programs (DRIP). This approach leverages the power of compounding by reinvesting dividend earnings back into the stock, making a snowball effect that will significantly grow an investment over time.

Long-term dividend investors can reap the advantages of the DRIP technique to construct substantial wealth, and Johnson & Johnson (NYSE:JNJ) is a primary candidate for those trying to vary into dividend millionaires in about ten years.

Trending: Recent fund backed by Jeff Bezos offering a 7-9% goal yield with monthly dividends start today for just $100.

Why Johnson & Johnson?

Johnson & Johnson, a world healthcare giant, has a long-standing status for stability, consistent dividend payments, and a powerful business model. Despite challenges, paying homage to recent legal battles and the spin-off of its consumer health division, the company stays a solid selection for dividend investors resulting from its diversified revenue streams across pharmaceuticals, medical devices, and consumer health products.

The company has a history of rewarding shareholders, with a dividend yield of roughly 2.85% and a five-year dividend growth rate of 6.04%. This regular dividend growth, coupled with its resilient stock price, makes J&J a phenomenal option for those attempting to leverage the power of compounding dividends.

Projected Growth Over 10 Years

Since the table below demonstrates, an initial investment of $50,000 in Johnson & Johnson, with monthly top-ups of $500, could grow to over $1 million by 2034, assuming the stock maintains its current annual dividend growth rate of 6.04% and a projected stock price growth rate of 8% per yr.

Don’t Miss Out: Industrial real estate has historically outperformed the stock market, but few investors have the capital or resources needed to take a position on this asset class. Start investing in business real estate today.

Recent Performance and Outlook

Johnson & Johnson’s stock has seen stable performance, with recent gains driven by strong earnings reports and the company’s strategic think about high-growth areas paying homage to oncology and immunology. The separation of its consumer health division, Kenvue, has allowed J&J to concentrate on its core businesses, potentially resulting in higher long-term growth prospects.

Story continues

Institutional investors are also showing confidence in Johnson & Johnson. In the first half of 2024, Vanguard increased its holdings by 2.5 million shares, while BlackRock added 1.8 million shares, signaling strong institutional support for the company’s future growth.

Analysts remain optimistic about Johnson & Johnson’s future, with several upgrading their price targets following the Kenvue spin-off. The company’s robust pipeline of recent drugs, particularly throughout the oncology sector, is predicted to drive revenue growth. Furthermore, J&J’s ongoing legal resolutions are liable to remove some uncertainty, further stabilizing the stock.

Diversifying with High-Yield Alternatives

While Johnson & Johnson offers a solid path to constructing wealth through dividends, investors also needs to contemplate diversifying their portfolios with high-yield alternatives. Two options value exploring are the Ascent Income Fund and the Arrived Private Credit Fund.

The Ascent Income Fund targets stable income from senior business real estate debt positions, offering a historical distribution yield of 10.38% backed by real assets. This fund provides a robust complement to dividend investing by offering payment priority and versatile liquidity options.

Similarly, the Arrived Private Credit Fund simplifies investing in short-term financing for real estate projects, providing attractive yields secured by quality residential real estate. With goal annualized dividends of 7-9%, this fund is an outstanding technique to balance risk and reward in a diversified investment strategy.

By investing in Johnson & Johnson and leveraging dividend compounding, along with exploring high-yield alternatives identical to the Ascent Income Fund and Arrived Private Credit Fund, investors can create a resilient, income-generating portfolio capable of weathering various market conditions. This approach can pave the technique to becoming a dividend millionaire inside the next decade.

This text Invest $50K in Johnson & Johnson to Turn right into a Dividend Millionaire in 10 Years originally appeared on Benzinga.com